Showcases Use of Causal Machine Learning and IBD Plexus(R) to Optimize Trial Execution BOSTON, Jan. 22, 2026 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, is today presenting new ...
PhaseV's Causal Machine Learning Predicts High Probability of Success in Multiple ALS Subgroups for NeuroSense's Phase 3 Trial CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- NeuroSense Therapeutics ...
Machines can learn not only to make predictions, but also to handle causal relationships. An international research team shows how this could make therapies safer, more efficient, and more ...
There is a missing ingredient in today’s artificial intelligence, which, when added, will make AI a truly indispensable partner in business and increase return on investment over the long haul. The ...
The manufacturing landscape is evolving rapidly, with intelligent systems increasingly promising to boost efficiency, quality, and overall competitiveness. Traditional machine learning (ML) has ...